Cancers (May 2022)

CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset

  • Giacomo Avesani,
  • Huong Elena Tran,
  • Giulio Cammarata,
  • Francesca Botta,
  • Sara Raimondi,
  • Luca Russo,
  • Salvatore Persiani,
  • Matteo Bonatti,
  • Tiziana Tagliaferri,
  • Miriam Dolciami,
  • Veronica Celli,
  • Luca Boldrini,
  • Jacopo Lenkowicz,
  • Paola Pricolo,
  • Federica Tomao,
  • Stefania Maria Rita Rizzo,
  • Nicoletta Colombo,
  • Lucia Manganaro,
  • Anna Fagotti,
  • Giovanni Scambia,
  • Benedetta Gui,
  • Riccardo Manfredi

DOI
https://doi.org/10.3390/cancers14112739
Journal volume & issue
Vol. 14, no. 11
p. 2739

Abstract

Read online

Purpose: Build predictive radiomic models for early relapse and BRCA mutation based on a multicentric database of high-grade serous ovarian cancer (HGSOC) and validate them in a test set coming from different institutions. Methods: Preoperative CTs of patients with HGSOC treated at four referral centers were retrospectively acquired and manually segmented. Hand-crafted features and deep radiomics features were extracted respectively by dedicated software (MODDICOM) and a dedicated convolutional neural network (CNN). Features were selected with and without prior harmonization (ComBat harmonization), and models were built using different machine learning algorithms, including clinical variables. Results: We included 218 patients. Radiomic models showed low performance in predicting both BRCA mutation (AUC in test set between 0.46 and 0.59) and 1-year relapse (AUC in test set between 0.46 and 0.56); deep learning models demonstrated similar results (AUC in the test of 0.48 for BRCA and 0.50 for relapse). The inclusion of clinical variables improved the performance of the radiomic models to predict BRCA mutation (AUC in the test set of 0.74). Conclusions: In our multicentric dataset, representative of a real-life clinical scenario, we could not find a good radiomic predicting model for PFS and BRCA mutational status, with both traditional radiomics and deep learning, but the combination of clinical and radiomic models improved model performance for the prediction of BRCA mutation. These findings highlight the need for standardization through the whole radiomic pipelines and robust multicentric external validations of results.

Keywords